Clinical Trials on Ocular Hypertension (OHT) in Switzerland

Total 396 results

Novartis

Completed

Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Hypertension

Switzerland, Germany
Idorsia Pharmaceuticals Ltd.

Terminated

Tezosentan in Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

United States, France, Switzerland
University of Bern

Completed

Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct (Euphrasia)

Preterm Neonates | Congenita Nasolacrimal Duct Obstruction | Ocular Discharge

Switzerland
University of Bern
University Hospital, Zürich; ISS AG

Completed

Assessment of Scan Quality of Sparse OCT Retina Scanner (MimoStudy01)

Macular Degeneration

Switzerland
University of Zurich

Completed

VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)

Macular Degeneration

Switzerland
University Hospital, Basel, Switzerland

Completed

Oxidative Stress in Patients With Age-Related Macular Degeneration

Macular Degeneration

Switzerland
Institute of Molecular and Clinical Ophthalmology...

Recruiting

Function and Imaging Assessments for G1961E-associated Stargardt Disease (FIRSTORBIT)

Stargardt Disease | Stargardt Disease 1 | Fundus Flavimaculatus | Macular Degeneration, Stargardt | Macular Dystrophy With Flecks, Type 1

Switzerland
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

Hypertension

Switzerland, Germany
Novartis

Completed

VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil

Hypertension

Switzerland, Germany
Novartis

Completed

VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients

Hypertension

Germany, Switzerland
Novartis

Completed

VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria

Hypertension

Switzerland, Germany
Novartis

Completed

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

Hypertension

Switzerland, Germany
Novartis

Completed

A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients

Hypertension

Germany, Switzerland
Novartis

Completed

Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

Hypertension

Switzerland, Germany
Novartis

Completed

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine

Hypertension

Switzerland, Germany
University Hospital, Basel, Switzerland
Medical University of Graz; University of Pittsburgh; Ludwig-Maximilians - University... and other collaborators

Unknown

Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy

Macular Edema

Austria, Switzerland
Institute of Molecular and Clinical Ophthalmology...
Boehringer Ingelheim

Active, not recruiting

Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study (OMEGA)

Age-Related Macular Degeneration | Geographic Atrophy | Visual Field Defect, Central Scotoma of Both Eyes

Switzerland
Novartis

Completed

Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients

Hypertension

Germany, Switzerland
University Hospital, Geneva
University of Lausanne Hospitals

Completed

Renal and Hormonal Effects of Pioglitazone

Hypertension | Diabetes

Switzerland
Pascal Vuilleumier

Unknown

Detection of Epileptiform Activity in Severe Preeclampsia

Preeclampsia

Switzerland
Insel Gruppe AG, University Hospital Bern

Completed

Botox Instead of Strabismus Surgery (BISS) (BISS)

Acquired Esotropia

Switzerland, France
Novartis

Completed

A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure

Hypertension

Switzerland
University Hospital Inselspital, Berne

Completed

Effect of Intradialytic Electrical Muscle Stimulation and Passive Leg Mobilisation on Blood Pressure and Dialysis Efficacy

Hypotension

Switzerland
University Hospital Inselspital, Berne

Completed

The Role of Macular Pigment in Patients With Age-related Macular Degeneration

Age Related Maculopathy

Switzerland
University Hospital Inselspital, Berne

Completed

Enhancement of Macular Pigment Density by Oral Lutein Supplementation (EMPOLS)

Age-Related Maculopathies

Switzerland
grégoire millet
Centre Hospitalier Universitaire Vaudois

Not yet recruiting

Intermittent Hypoxia-hyperoxia Conditioning as a New Therapeutic Intervention to Reduce Hypertension (HyperIHHC) (HyperIHHC)

Hypertension

Switzerland
Swiss Paraplegic Centre Nottwil

Completed

Prevention of Orthostatic Hypotension With Electric Stimulation in Persons With Acute SCI

Orthostatic Hypotension | Spinal Cord Injury

Switzerland
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension

Essential Hypertension

Finland, Norway, Sweden, France, Germany, Italy, Turkey, Argentina, Chile, Ecuador, Spain, Switzerland
Boehringer Ingelheim

Terminated

Global Atrophie Biomarker Evaluation Study (GABiE) (GABiE)

Age-related Macular Degeneration

United States, Switzerland
Heidelberg University
Merck Sharp & Dohme LLC

Recruiting

Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH (ESRA)

Systemic Sclerosis | Pulmonary Vascular Disorder | Primary Pulmonary Hypertension | Other Systemic Involvement of Connective Tissue

Austria, United Kingdom, Germany, France, Switzerland, Italy
Sankyo Pharma Gmbh

Completed

Olmesartan in Essential Hypertension

Essential Hypertension

Austria, Germany, Italy, Netherlands, Portugal, Spain, Switzerland, United Kingdom
Novartis

Completed

VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women

Hypertension

Switzerland, Germany
Novartis

Completed

A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension

Hypertension

Switzerland, Spain, Hungary, Germany
University of Zurich

Withdrawn

Effect of Catheter-based Radiofrequency Ablation Therapy in Patient With Therapy-resistant Hypertension and Sleep Apnea Syndrome

Therapy-resistant Hypertension and Sleep Apnea

Switzerland
University of Zurich

Unknown

Lymphoma in the Orbit

Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma

Switzerland
Dr. med. Katja Hatz
Vista Klinik

Completed

Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients (COSP)

Macular Degeneration

Switzerland
Vincenzo Cannizzaro

Completed

Copeptin and Arterial Hypotension in Critically Ill Paediatric and Neonatal Intensive Care Patients (COPNIC)

Arterial Hypotension in Critically Ill Neonatal and Pediatric Patients

Switzerland
Klinikum Wels-Grieskirchen
European Regional Development Fund; Austrian Society of Hypertension; I.E.M....

Completed

Central Blood Pressure Over 24 Hours (ABPM) and Left Ventricular Mass

Suspected Arterial Hypertension

Switzerland, Austria, Germany, Greece, Italy, Spain, United Kingdom
Allergan
Molecular Partners AG

Terminated

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

Wet Age-Related Macular Degeneration

Switzerland, France, Czech Republic
University Hospital, Basel, Switzerland

Recruiting

Association of Intraoperative Blood Pressure Excursions Below Cerebral Autoregulatory Boundaries With Organ Injury Following Major Noncardiac Surgery (AR-NONCARDIAC)

Intraoperative Arterial Hypotension

Switzerland
University Hospital, Geneva

Completed

Post-preeclampsia Renal Project: Study of Nephroprotection in Women Having Suffered Preeclampsia (RPPEC)

Renal Alteration

Switzerland
CVRx, Inc.

Completed

Device Based Therapy in Hypertension Extension Trial (DEBuT-HET)

Hypertension

Netherlands, Switzerland, Germany
Novartis

Completed

Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration

Wet Age-Related Macular Degeneration

United Kingdom, Switzerland
University Hospital, Geneva

Completed

Increased Salt Sensitivity of Ambulatory Blood Pressure in Women With a History of Severe Preeclampsia

Preeclampsia

Switzerland
University Hospital Inselspital, Berne
University of Cape Town; National Council of Scientific and Technical Research...

Unknown

Electroencephalographic Effects of Spinal Anaesthesia During Caesarean Delivery in Preeclampsia

Pre-Eclampsia | Effects of; Anesthesia, Spinal and Epidural, in Pregnancy

Switzerland
Actelion

Completed

Bosentan in Children With Pulmonary Arterial Hypertension (FUTURE-1)

Pulmonary Arterial Hypertension

United States, France, Netherlands, Italy, Germany, Switzerland, United Kingdom
Kantonsspital Münsterlingen

Completed

Safety Study of Two Regimen for Sedation for Transesophageal Echocardiography

Hypotension

Switzerland
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

Hypertension

Germany, Switzerland, United Kingdom
University Hospital Inselspital, Berne

Completed

A Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?

Renal Failure | Renal Transplantation | Living Donors

Switzerland
University of Zurich

Completed

OVEMP in Myasthenia

Myasthenia Gravis, Ocular

Switzerland

Clinical Trials on Ocular Hypertension (OHT) in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations